() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: 8IS1

AB LABS AWARDED SALES LICENSE

March 22, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company’s licensed producer AB Labs Inc. (“AB Labs") has received a medical sales and processing license from Health Canada effective March 16, 2019, pursuant to the Cannabis Act and Cannabis Regulations (“CACR”).
Read more

INVICTUS ANNOUNCES APPOINTMENT OF NEW CFO

INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce the appointment of Harbir Toor as Chief Financial Officer (“CFO”) on March 7, 2019, to succeed Dylan Easterbrook. 
Read more

INVICTUS HIRES INTERIM CHIEF MARKETING OFFICER AND EXPANDS INVESTOR RELATIONS

Feb. 12, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has hired a prominent Toronto based strategic consulting agency (the “Agency”) as interim Chief Marketing Officer (“interim CMO”), strategic consulting partner, creative agency partner and live events partner. The contract duration is six months and began on January 1, 2019.
Read more